vs
JBG SMITH Properties（JBGS）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
JBG SMITH Properties的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.7倍（$127.6M vs $75.5M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs -2.5%），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs -6.3%）
JBG SMITH Properties是一家总部位于马里兰州贝塞斯达的上市房地产投资信托公司，专注于持有并运营房地产资产，是美国商业地产领域的专业运营机构，面向市场提供多元化的不动产投资与管理服务。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
JBGS vs PBYI — 直观对比
营收规模更大
JBGS
是对方的1.7倍
$75.5M
营收增速更快
PBYI
高出30.2%
-2.5%
两年增速更快
PBYI
近两年复合增速
-6.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $127.6M | $75.5M |
| 净利润 | $-45.5M | — |
| 毛利率 | — | 69.3% |
| 营业利润率 | -47.5% | 22.7% |
| 净利率 | -35.7% | — |
| 营收同比 | -2.5% | 27.7% |
| 净利润同比 | 24.0% | — |
| 每股收益（稀释后） | $-0.76 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收JBGSPBYI
| Q4 25 | $127.6M | $75.5M | ||
| Q3 25 | $123.9M | $54.5M | ||
| Q2 25 | $126.5M | $52.4M | ||
| Q1 25 | $120.7M | $46.0M | ||
| Q4 24 | $130.8M | $59.1M | ||
| Q3 24 | $136.0M | $80.5M | ||
| Q2 24 | $135.3M | $47.1M | ||
| Q1 24 | $145.2M | $43.8M |
净利润JBGSPBYI
| Q4 25 | $-45.5M | — | ||
| Q3 25 | $-28.6M | $8.8M | ||
| Q2 25 | $-19.2M | $5.9M | ||
| Q1 25 | $-45.7M | $3.0M | ||
| Q4 24 | $-59.9M | — | ||
| Q3 24 | $-27.0M | $20.3M | ||
| Q2 24 | $-24.4M | $-4.5M | ||
| Q1 24 | $-32.3M | $-4.8M |
毛利率JBGSPBYI
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
营业利润率JBGSPBYI
| Q4 25 | -47.5% | 22.7% | ||
| Q3 25 | -27.5% | 17.6% | ||
| Q2 25 | -18.4% | 12.7% | ||
| Q1 25 | -44.7% | 8.7% | ||
| Q4 24 | -53.6% | 22.6% | ||
| Q3 24 | -22.4% | 27.4% | ||
| Q2 24 | -24.3% | -4.6% | ||
| Q1 24 | -30.1% | -5.3% |
净利率JBGSPBYI
| Q4 25 | -35.7% | — | ||
| Q3 25 | -23.1% | 16.2% | ||
| Q2 25 | -15.2% | 11.2% | ||
| Q1 25 | -37.9% | 6.5% | ||
| Q4 24 | -45.8% | — | ||
| Q3 24 | -19.8% | 25.2% | ||
| Q2 24 | -18.0% | -9.6% | ||
| Q1 24 | -22.2% | -11.0% |
每股收益（稀释后）JBGSPBYI
| Q4 25 | $-0.76 | $0.26 | ||
| Q3 25 | $-0.48 | $0.17 | ||
| Q2 25 | $-0.29 | $0.12 | ||
| Q1 25 | $-0.56 | $0.06 | ||
| Q4 24 | $-0.70 | $0.40 | ||
| Q3 24 | $-0.32 | $0.41 | ||
| Q2 24 | $-0.27 | $-0.09 | ||
| Q1 24 | $-0.36 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $75.3M | $97.5M |
| 总债务越低越好 | — | $22.7M |
| 股东权益账面价值 | $1.2B | $130.3M |
| 总资产 | $4.4B | $216.3M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资JBGSPBYI
| Q4 25 | $75.3M | $97.5M | ||
| Q3 25 | $64.4M | $94.4M | ||
| Q2 25 | $61.4M | $96.0M | ||
| Q1 25 | $81.3M | $93.2M | ||
| Q4 24 | $145.8M | $101.0M | ||
| Q3 24 | $137.0M | $96.7M | ||
| Q2 24 | $163.5M | $96.8M | ||
| Q1 24 | $220.5M | $107.2M |
总债务JBGSPBYI
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
股东权益JBGSPBYI
| Q4 25 | $1.2B | $130.3M | ||
| Q3 25 | $1.2B | $115.3M | ||
| Q2 25 | $1.3B | $104.7M | ||
| Q1 25 | $1.6B | $97.1M | ||
| Q4 24 | $1.8B | $92.1M | ||
| Q3 24 | $1.9B | $71.1M | ||
| Q2 24 | $2.0B | $48.5M | ||
| Q1 24 | $2.1B | $51.0M |
总资产JBGSPBYI
| Q4 25 | $4.4B | $216.3M | ||
| Q3 25 | $4.4B | $202.9M | ||
| Q2 25 | $4.5B | $194.9M | ||
| Q1 25 | $4.7B | $196.2M | ||
| Q4 24 | $5.0B | $213.3M | ||
| Q3 24 | $5.2B | $220.7M | ||
| Q2 24 | $5.3B | $205.0M | ||
| Q1 24 | $5.4B | $214.1M |
负债/权益比JBGSPBYI
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $73.3M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | — | $14.4M |
| 自由现金流率自由现金流/营收 | — | 19.1% |
| 资本支出强度资本支出/营收 | — | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $41.7M |
8季度趋势，按日历期对齐
经营现金流JBGSPBYI
| Q4 25 | $73.3M | $14.4M | ||
| Q3 25 | $8.9M | $9.7M | ||
| Q2 25 | $18.8M | $14.1M | ||
| Q1 25 | $12.9M | $3.6M | ||
| Q4 24 | $129.4M | $15.6M | ||
| Q3 24 | $26.4M | $11.0M | ||
| Q2 24 | $23.8M | $1.0M | ||
| Q1 24 | $37.0M | $11.2M |
自由现金流JBGSPBYI
| Q4 25 | — | $14.4M | ||
| Q3 25 | — | $9.7M | ||
| Q2 25 | — | $14.1M | ||
| Q1 25 | — | $3.6M | ||
| Q4 24 | — | $15.6M | ||
| Q3 24 | — | $11.0M | ||
| Q2 24 | — | $1.0M | ||
| Q1 24 | — | — |
自由现金流率JBGSPBYI
| Q4 25 | — | 19.1% | ||
| Q3 25 | — | 17.7% | ||
| Q2 25 | — | 26.8% | ||
| Q1 25 | — | 7.7% | ||
| Q4 24 | — | 26.4% | ||
| Q3 24 | — | 13.7% | ||
| Q2 24 | — | 2.1% | ||
| Q1 24 | — | — |
资本支出强度JBGSPBYI
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | — | 0.0% |
现金转化率JBGSPBYI
| Q4 25 | — | — | ||
| Q3 25 | — | 1.10× | ||
| Q2 25 | — | 2.41× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.54× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
